Barely Significant
← all excerpts

Interleukin 8, a Biomarker to Differentiate Guillain-Barré Syndrome From CIDP.

Neurol Neuroimmunol Neuroinflamm · 2021 · PMC8216426 · PMID 34140310

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantp < 0.001actually significant
Despite the low number of patients with acute CIDP analyzed, the IL-8 difference with AIDP remains highly significant ( p < 0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.